Sakar Healthcare earnings call announcements

Earnings CallSakar Healthcare Ltd SAKAR

Sakar Healthcare Earnings Call Transcript: Key Takeaways

Sakar Healthcare delivered exceptional growth as its oncology segment scales, with EBITDA doubling and margins expanding significantly due to product-mix shifts. Management is pivoting from a non-oncology focus to high-margin oncology formulations and APIs.

Call

Guides 35% growth

Earnings CallSakar Healthcare Ltd SAKAR

Sakar Healthcare Investor Presentation: Key Takeaways

Q2FY27 consolidated revenue Rs87.4 Cr (+52% YoY), EBITDA Rs24.4 Cr (28% margin), PAT Rs11.3 Cr (+149%); pitch centres on oncology integration.

Earnings CallSakar Healthcare Ltd SAKARAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Sakar Healthcare Earnings Call Transcript: Key Takeaways

Sakar Healthcare Q1 FY27 results show strong oncology pivot with 38% YoY revenue growth and 120% profit jump.

Call

Guides 100% growth